Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CTI BIOPHARMA CORP (CTI)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -93.0-97.9-52.5-40.0-29.4-45.0-52.0-122.6
Depreciation and amortization  2.00.50.50.50.60.70.81.0
Asset impairment charges        1.21.3
Stock-based compensation  10.04.74.35.26.45.713.314.8
Change in working capital   [+]-7.97.9-2.4-5.90.8-12.80.56.6
Other operating activities  7.7-0.17.812.4-18.112.1-40.63.6
Cash from operations  -81.2-84.9-42.2-27.8-39.8-39.3-76.7-95.2
   
Capital expenditures  0.00.00.00.00.00.0-0.1-0.1
Purchases of intangible assets  -25.0       
Purchases of short-term investments, net  -48.912.0-9.628.1-30.50.0  
Cash from investing  -73.912.0-9.628.1-30.50.0-0.1-0.1
   
Issuance of common stock, net      64.20.0 15.1
Option exercises  4.90.40.10.00.10.0  
Other cash from financing  125.098.361.2-5.6-0.639.0-7.4136.9
Cash from financing  120.097.961.1-5.663.539.0-7.4152.0
   
Free cash flow  -81.2-84.9-42.2-27.8-39.9-39.3-76.8-95.3
        Per share (diluted)  ($0.71)($0.94)($0.59)($0.48)($0.71)($1.08)($2.75)($5.06)
   
Cash paid for interest  6.12.00.51.01.22.04.42.1

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy